Aram Prof. Dr. Dr. Prokop

Prof. Dr. Aram Prof. Dr. Dr. Prokop


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NWNicola Leonie Wilke
Nicola Leonie Wilke
HBHilke Burmeister
Hilke Burmeister
CFCorazon Frias
Corazon Frias
IOIngo Ott
Ingo Ott
APAram Prof. Dr. Dr. Prokop
Aram Prof. Dr. Dr. Prokop
Ruthenium(II) complexes with N-heterocyclic carbene (NHC) ligands have recently attracted attention as novel chemotherapeutic agents. The complex HB324 was intensively studied as an apoptosis-inducing compound in resistant cell lines. HB324 induced apoptosis via mitochondrial pathways. Of particular interest is the upregulation of the Harakiri resistance protein, which inhibits the anti-apoptotic and death repressor proteins Bcl-2 (B-cell lymphoma 2) and BCL-xL (B-cell lymphoma-extra large). Moreover, HB324 showed synergistic activity with various established anticancer drugs and overcame resistance in several cell lines, such as neuroblastoma cells. In conclusion, HB324 showed promising potential as a novel anticancer agent in vitro, suggesting further investigations on this and other preclinical ruthenium drug candidates.

28 August 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
FBFranziska Bannwart
Franziska Bannwart
LRLeon F. Richter
Leon F. Richter
SSSimon Stifel
Simon Stifel
JRJohanna Rueter
Johanna Rueter
HLHolger N. Lode
Holger N. Lode
APAram Prof. Dr. Dr. Prokop
Aram Prof. Dr. Dr. Prokop
From previous studies, it is evident that metal-organic gold(I) complexes have antiproliferative activities. The aim of this study is not only to find new anticancer agents but also to overcome existing cytostatic resistance in cancer cells. The synthesis and medicinal evaluation of two cationic 1,3-disubstituted gold(I) bis-tetrazolylidene complexes 1 and 2 are reported. To determine apoptosis-inducing properties of the complexes, DNA fragmentation was measured using propidium iodide staining followed by flow cytometry. Gold(I) complex 1 targets explicitly malignant cells, effectively inhibiting their growth and selectively inducing apoptosis without signs of necrosis. Even in cells resistant to common treatments such as doxorubicin, it overcomes multidrug resistance and sensitizes existing drug-resistant cells to common cytostatic drugs. It is assumed that gold(I) complex 1 involves the mitochondrial pathway in apoptosis and targets members of the BCL-2 family, enhancing its potential as a therapeutic agent in cancer treatment.

2 August 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
SBSofia Basova
Sofia Basova
NWNathalie Wilke
Nathalie Wilke
JKJan Christoph Koch
Jan Christoph Koch
APAram Prof. Dr. Dr. Prokop
Aram Prof. Dr. Dr. Prokop
ABAlbrecht Berkessel
Albrecht Berkessel
CNChe Julius Ngwa
Che Julius Ngwa
The rapid development of parasite drug resistance as well as the lack of medications targeting both the asexual and the sexual blood stages of the malaria parasite necessitate the search for novel antimalarial compounds. Eleven organoarsenic compounds were synthesized and tested for their effect on the asexual blood stages and sexual transmission stages of the malaria parasite Plasmodium falciparum using in vitro assays. The inhibitory potential of the compounds on blood stage viability was tested on the chloroquine (CQ)-sensitive 3D7 and the CQ-resistant Dd2 strain using the Malstat assay. The most effective compounds were subsequently investigated for their effect on impairing gametocyte development and gametogenesis, using the gametocyte-producing NF54 strain in respective cell-based assays. Their potential toxicity was investigated on leukemia cell line Nalm-6 and non-infected erythrocytes. Five out of the 11 compounds showed antiplasmodial activities against 3D7, with half-maximal inhibitory concentration (IC50) values ranging between 1.52 and 8.64 µM. Three of the compounds also acted against Dd2, with the most active compound As-8 exhibiting an IC50 of 0.35 µM. The five compounds also showed significant inhibitory effects on the parasite sexual stages at both IC50 and IC90 concentrations with As-8 displaying the best gametocytocidal activity. No hemolytic and cytotoxic effect was observed for any of the compounds. The organoarsenic compound As-8 may represent a good lead for the design of novel organoarsenic drugs with combined antimalarial and transmission blocking activities.

8 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
JBJennifer Baas
Jennifer Baas
SBSebastian Bieringer
Sebastian Bieringer
CFCorazon Frias
Corazon Frias
JFJerico Frias
Jerico Frias
CSCarolina Soehnchen
Carolina Soehnchen
APAram Prof. Dr. Dr. Prokop
Aram Prof. Dr. Dr. Prokop
Isatis tinctoria and its indigo dyes have already provided highly active anti-leukaemic lead compounds, with the focus mainly being on indirubin, whereas indigo itself is inactive. There are many more indigoids to find in this plant extract, for example, quingdainone, an indigoid derived from tryptanthrin. We present here a new synthesis of hitherto neglected substituted quingdainones, which is very necessary due to their poor solubility behaviour, and a structure-dependent anti-leukaemic activity study of a number of compounds. Substituted α-phenylaminoacrylic acid was synthesised by hydrogen sulfide extrusion from an analogue mercaptoacetic acid, available from the condensation of rhodanin and a substituted tryptanthrin. It is shown that just improving water solubility does not increase anti-leukaemic activity, since a quingdainone carboxylic acid is inactive compared to dihydroxyquingdainone. The most effective compound, dihydroxyquingdainone with an AC50 of 7.5 µmole, is further characterised, revealing its ability to overcome multidrug resistance in leukaemia cells (Nalm-6/BeKa) with p-glycoprotein expression.

26 March 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
WBWolfgang R. E. Büchele
Wolfgang R. E. Büchele
TSTim P. Schlachta
Tim P. Schlachta
AGAndreas L. Gebendorfer
Andreas L. Gebendorfer
JPJenny Pamperin
Jenny Pamperin
LRLeon F. Richter
Leon F. Richter
FKFritz E. Kühn
Fritz E. Kühn
Synthesis and characterization of the first two cyclic ethylene-bridged tetradentate NHC ligands, with an unsaturated (imidazole) and saturated backbone (2-imidazoline), are described. Complexes of both ligands containing palladium(II) have been obtained. For platinum(II) and gold(III), only the unsaturated tetracarbene complexes could be isolated. The attempts to synthesize a methylene-bridged 2-imidazoline macrocycle are also described. Furthermore, a novel bisimidazolinium ligand precursor and its open-chain PdII and PtII tetracarbene complexes are obtained. Finally, it is shown that the unsaturated gold(III) tetracarbene is able to induce apoptosis in malignant SK-N-AS neuroblastoma cells via the mitochondrial and ROS pathway and overcomes resistance to cisplatin in vitro.

30 June 2022 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
LOLiliane Abodo Onambele
Liliane Abodo Onambele
NHNatalie Hoffmann
Natalie Hoffmann
LKLisa Kater
Lisa Kater
LHLars Hemmersbach
Lars Hemmersbach
JNJörg-Martin Neudörfl
Jörg-Martin Neudörfl
APAram Prof. Dr. Dr. Prokop
Aram Prof. Dr. Dr. Prokop
The diarylethyne cobalt carbonyl complex NAHO27 selectively induces apoptosis in cancer cells at low μM concentrations via the mitochondrial pathway. It is also active against resistant cells, showing a strong synergistic effect with vincristine.